Medicare Plans Should Halt Off-Label Avastin Step Therapy Amid Supply Disruption, CMS Told

 
• By Cathy Kelly
  
Prescribers have long opposed step therapy in the anti-VEGF category. (Shutterstock)

More from Medicare

More from Geography